Skip main navigation

Cookies Notification

We use cookies on this site to enhance your user experience. By continuing to browse the site, you consent to the use of our cookies. Learn More
×

System Upgrade on Tue, May 28th, 2024 at 2am (EDT)

Existing users will be able to log into the site and access content. However, E-commerce and registration of new users may not be available for up to 12 hours.
For online purchase, please visit us again. Contact us at customercare@wspc.com for any enquiries.

SEARCH GUIDE  Download Search Tip PDF File

  • articleOpen Access

    G6PD-MutDB: A MUTATION AND PHENOTYPE DATABASE OF GLUCOSE-6-PHOSPHATE (G6PD) DEFICIENCY

    Glucose-6-phosphate dehydrogenase (G6PD) deficiency is the most common hereditary enzymatic disorder of red blood cells in humans due to mutations in the G6PD gene. The G6PD enzyme catalyzes the first step in the pentose phosphate pathway to protect cells against oxidative stress. Mutations in the G6PD gene will cause functional variants with various biochemical and clinical phenotypes. So far, about 160 mutations along with more than 400 biochemical variants have been described. G6PD-MutDB is a disease-specific resource of G6PD deficiency, collecting and integrating G6PD mutations with biochemical and clinical phenotypes. Data of G6PD deficiency is manually extracted from published papers, focusing primarily on variants with identified mutation and well-described quantitative phenotypes. G6PD-MutDB implements an approach, CNSHA predictor, to help identify a potential chronic non-spherocytic hemolytic anemia (CNSHA) phenotype of an unknown mutation. G6PD-MutDB is believed to facilitate analysis of relationship between molecular mutation and functional phenotype of G6PD deficiency owing to convenient data resource and useful tools. This database is available from .

  • chapterNo Access

    G6PD DEFICIENCY AND APPLICATION OF THE MPTP TECHNIQUE

    Glucose-6-phosphate dehydrogenase (G6PD) deficiency is an X-linked recessive enzyme disorder that affects an estimated 200-400 million people. More than four hundred biochemical variants have been identified reflecting the vast heterogeneity of this disorder. At the molecular level, less than a hundred mutations have been characterized indicating a need for a rapid and efficient approach for mutational screening of G6PD deficient individuals in different populations. A technique called multiplex PCR using multiple tandem forward primers and a common reverse primer (MPTP technique) was recently developed. It was initially tested in Singapore population where the incidence of this deficiency occurs at approximately 3% of newborn males. The MPTP technique allows quick and comprehensive screening of point mutations and can be adopted to detect common variants such as 1376G→T (G6PD Canton) and 1388G→A (G6PD Kaiping) in mutation hot spots for specific populations. This paper presents a brief review on G6PD deficiency and the application of the MPTP technique for screening this disorder.